231 related articles for article (PubMed ID: 29272488)
1. Thiopurine Treatment in Ulcerative Colitis: A Critical Review of the Evidence for Current Clinical Practice.
van Gennep S; de Boer NK; D'Haens GR; Löwenberg M
Inflamm Bowel Dis; 2017 Dec; 24(1):67-77. PubMed ID: 29272488
[TBL] [Abstract][Full Text] [Related]
2. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
Timmer A; McDonald JW; Tsoulis DJ; Macdonald JK
Cochrane Database Syst Rev; 2012 Sep; (9):CD000478. PubMed ID: 22972046
[TBL] [Abstract][Full Text] [Related]
3. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
Timmer A; Patton PH; Chande N; McDonald JW; MacDonald JK
Cochrane Database Syst Rev; 2016 May; 2016(5):CD000478. PubMed ID: 27192092
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis.
Gisbert JP; Linares PM; McNicholl AG; Maté J; Gomollón F
Aliment Pharmacol Ther; 2009 Jul; 30(2):126-37. PubMed ID: 19392869
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus therapy as an alternative to thiopurines for maintaining remission in patients with refractory ulcerative colitis.
Yamamoto S; Nakase H; Matsuura M; Masuda S; Inui K; Chiba T
J Clin Gastroenterol; 2011 Jul; 45(6):526-30. PubMed ID: 21336140
[TBL] [Abstract][Full Text] [Related]
6. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
Timmer A; McDonald JW; Macdonald JK
Cochrane Database Syst Rev; 2007 Jan; (1):CD000478. PubMed ID: 17253451
[TBL] [Abstract][Full Text] [Related]
7. Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy.
Balram B; Lubov J; Theoret Y; Afif W; Bitton A; Wild G; Lakatos PL; Bessissow T
Dig Dis Sci; 2021 May; 66(5):1650-1657. PubMed ID: 32591969
[TBL] [Abstract][Full Text] [Related]
8. Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn's disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource.
Stournaras E; Qian W; Pappas A; Hong YY; Shawky R; ; Raine T; Parkes M;
Gut; 2021 Apr; 70(4):677-686. PubMed ID: 33004550
[TBL] [Abstract][Full Text] [Related]
9. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety.
Dubinsky MC
Clin Gastroenterol Hepatol; 2004 Sep; 2(9):731-43. PubMed ID: 15354273
[TBL] [Abstract][Full Text] [Related]
10. Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study.
Prieux-Klotz C; Nahon S; Amiot A; Sinayoko L; Galéano-Cassaz C; Chaussade S; Coriat R; Lahmek P; Abitbol V
Dig Dis Sci; 2017 Feb; 62(2):473-480. PubMed ID: 27853898
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
Khan KJ; Dubinsky MC; Ford AC; Ullman TA; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):630-42. PubMed ID: 21407186
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of optimised thiopurine therapy in patients with moderate-to-severe ulcerative colitis: retrospective long-term follow-up from two randomised trials.
Mertz Nielsen A; Theede K; Gluud LL; Kiszka-Kanowitz M
Scand J Gastroenterol; 2024 Jun; 59(6):669-673. PubMed ID: 38444060
[TBL] [Abstract][Full Text] [Related]
13. Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study.
Khan N; Abbas AM; Lichtenstein GR; Loftus EV; Bazzano LA
Gastroenterology; 2013 Nov; 145(5):1007-1015.e3. PubMed ID: 23891975
[TBL] [Abstract][Full Text] [Related]
14. Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients.
Kennedy NA; Kalla R; Warner B; Gambles CJ; Musy R; Reynolds S; Dattani R; Nayee H; Felwick R; Harris R; Marriott S; Senanayake SM; Lamb CA; Al-Hilou H; Gaya DR; Irving PM; Mansfield J; Parkes M; Ahmad T; Cummings JR; Arnott ID; Satsangi J; Lobo AJ; Smith M; Lindsay JO; Lees CW
Aliment Pharmacol Ther; 2014 Dec; 40(11-12):1313-23. PubMed ID: 25284134
[TBL] [Abstract][Full Text] [Related]
15. [Role of thiopurine agents in ulcerative colitis].
Chaparro M; Gisbert JP
Gastroenterol Hepatol; 2011 Dec; 34 Suppl 3():30-5. PubMed ID: 25443224
[TBL] [Abstract][Full Text] [Related]
16. Predictors of Thiopurine Treatment Failure in Biologic-Naïve Ulcerative Colitis Patients.
Thapa SD; Hadid H; Usman M; Imam W; Hassan A; Schairer J; Jafri SM; Kaur N
Dig Dis Sci; 2016 Jan; 61(1):230-7. PubMed ID: 26511478
[TBL] [Abstract][Full Text] [Related]
17. Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis.
Armuzzi A; Pugliese D; Danese S; Rizzo G; Felice C; Marzo M; Andrisani G; Fiorino G; Nardone OM; De Vitis I; Papa A; Rapaccini GL; Guidi L
Inflamm Bowel Dis; 2014 Aug; 20(8):1368-74. PubMed ID: 24983979
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of long-term thiopurine maintenance treatment for ulcerative colitis in Turkey: A single-center experience.
Özgenç F; Karakoyun M; Ecevit Ç; Hekimci H; Kıran Taşçı E; Erdemir G
Turk J Gastroenterol; 2018 Nov; 29(6):650-654. PubMed ID: 30381272
[TBL] [Abstract][Full Text] [Related]
19. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
[TBL] [Abstract][Full Text] [Related]
20. Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study.
Hyams JS; Lerer T; Mack D; Bousvaros A; Griffiths A; Rosh J; Otley A; Evans J; Stephens M; Kay M; Keljo D; Pfefferkorn M; Saeed S; Crandall W; Michail S; Kappelman MD; Grossman A; Samson C; Sudel B; Oliva-Hemker M; Leleiko N; Markowitz J;
Am J Gastroenterol; 2011 May; 106(5):981-7. PubMed ID: 21224840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
